News
Foundation and AlphaNet honor former CSL president Peter Turner as "friend of the Alpha-1 community"
The Alpha-1 Foundation and AlphaNet have honored Peter Turner for his contributions to the Alpha-1 community. Turner recently left his position as president of CSL Behring after seven years of heading the company,
CSL Behring manufactures and markets plasma and protein-based therapies, including Zemaira, an augmentation therapy for Alpha-1 Antitrypsin Deficiency.
TURNER HONORED — Peter Turner is honored for his contributions to the Alpha-1 community with a painting, “Dreamtime Sisters,” by Colleen Wallace Nungari, a well-known Australian Aboriginal painter. From left are Gordon Cadwgan, Robert Barrett, Turner, John Walsh and Adam Wanner, MD.
“Peter Turner has proven himself a friend of the Alpha-1 community,” said John Walsh, Foundation president & CEO. “Under his leadership, CSL’s commitment to essential research has added energy to our efforts to find new therapies and ultimately a cure for Alpha-1.”
Robert Barrett, AlphaNet CEO, presented Turner with a painting called “Dreamtime Sisters,” one of a popular series by Colleen Wallace Nungari, an Aboriginal painter from central Australia.
According to Australian Aboriginal beliefs, “dreamtime” describes the period before living memory when spirits emerged from the earth and sky to create land forms and living creatures. Dreamtime stories are passed down through the generations, establish customs and set down the social and moral order.
In the painting, Nungari depicts her ancestral spirit figures dancing. Their role is to watch over the home and guide the family.
Turner, president of CSL Behring since 2004, left his post in July.
His successor is Paul Perreault, who was CSL’s executive vice president of commercial operations. Turner continues to serve as an executive director of the company.
